Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

Comparison of escitalopram and citalopram in outpatients with severe major depressive disorder: a prospective, naturalistic, 8-week study.

Lançon C, Sapin C, Note I, Farisse J.

Int J Psychiatry Clin Pract. 2006;10(2):131-7. doi: 10.1080/13651500600579290.

PMID:
24940963
2.

Efficacy, effectiveness and efficiency of escitalopram in the treatment of major depressive and anxiety disorders.

Lam RW, Annemans L.

Expert Rev Pharmacoecon Outcomes Res. 2007 Dec;7(6):559-76. doi: 10.1586/14737167.7.6.559.

PMID:
20528319
3.
4.

Escitalopram in the treatment of major depressive disorder: a meta-analysis.

Kennedy SH, Andersen HF, Thase ME.

Curr Med Res Opin. 2009 Jan;25(1):161-75. doi: 10.1185/03007990802622726 .

PMID:
19210149
5.

Superiority of escitalopram to paroxetine in the treatment of depression.

Kasper S, Baldwin DS, Larsson Lönn S, Boulenger JP.

Eur Neuropsychopharmacol. 2009 Apr;19(4):229-37. doi: 10.1016/j.euroneuro.2008.12.003. Epub 2009 Jan 29.

PMID:
19185467
6.

Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis.

Cipriani A, Furukawa TA, Salanti G, Geddes JR, Higgins JP, Churchill R, Watanabe N, Nakagawa A, Omori IM, McGuire H, Tansella M, Barbui C.

Lancet. 2009 Feb 28;373(9665):746-58. doi: 10.1016/S0140-6736(09)60046-5. Review.

PMID:
19185342
7.

Escitalopram and duloxetine in major depressive disorder: a pharmacoeconomic comparison using UK cost data.

Wade AG, Fernández JL, François C, Hansen K, Danchenko N, Despiegel N.

Pharmacoeconomics. 2008;26(11):969-81.

PMID:
18850765
8.

Impact of escitalopram treatment on Quality of Life Enjoyment and Satisfaction Questionnaire scores in major depressive disorder and generalized anxiety disorder.

Demyttenaere K, Andersen HF, Reines EH.

Int Clin Psychopharmacol. 2008 Sep;23(5):276-86. doi: 10.1097/YIC.0b013e328303ac5f.

PMID:
18703937
9.

Comparison of escitalopram versus citalopram for the treatment of major depressive disorder in a geriatric population.

Wu E, Greenberg PE, Yang E, Yu A, Erder MH.

Curr Med Res Opin. 2008 Sep;24(9):2587-95. doi: 10.1185/03007990802303525 . Epub 2008 Jul 31.

PMID:
18674407
10.

Are SNRIs more effective than SSRIs? A review of the current state of the controversy.

Thase ME.

Psychopharmacol Bull. 2008;41(2):58-85. Review.

PMID:
18668017
11.

Escitalopram and duloxetine in the treatment of major depressive disorder: a pooled analysis of two trials.

Lam RW, Andersen HF, Wade AG.

Int Clin Psychopharmacol. 2008 Jul;23(4):181-7. doi: 10.1097/YIC.0b013e3282ffdedc.

PMID:
18545055
12.

Escitalopram in the acute treatment of depressed patients aged 60 years or older.

Bose A, Li D, Gandhi C.

Am J Geriatr Psychiatry. 2008 Jan;16(1):14-20. doi: 10.1097/JGP.0b013e3181591c09.

PMID:
18165459
13.
14.

A surveillance study of escitalopram treatment of depressed patients.

Anders M, Tuma I, Rösslerova H.

Expert Opin Pharmacother. 2008 Jan;9(1):1-6.

PMID:
18076333
15.

Comprehensive analysis of remission (COMPARE) with venlafaxine versus SSRIs.

Nemeroff CB, Entsuah R, Benattia I, Demitrack M, Sloan DM, Thase ME.

Biol Psychiatry. 2008 Feb 15;63(4):424-34. Epub 2007 Sep 24.

PMID:
17888885
16.

Escitalopram therapy for major depression and anxiety disorders.

Baldwin DS, Reines EH, Guiton C, Weiller E.

Ann Pharmacother. 2007 Oct;41(10):1583-92. Epub 2007 Sep 11. Review.

PMID:
17848424
17.

Changes in sexual functioning associated with duloxetine, escitalopram, and placebo in the treatment of patients with major depressive disorder.

Clayton A, Kornstein S, Prakash A, Mallinckrodt C, Wohlreich M.

J Sex Med. 2007 Jul;4(4 Pt 1):917-29.

PMID:
17627739
19.

Escitalopram prevents relapse in older patients with major depressive disorder.

Gorwood P, Weiller E, Lemming O, Katona C.

Am J Geriatr Psychiatry. 2007 Jul;15(7):581-93.

PMID:
17586783
20.

Double-blind comparison of escitalopram and duloxetine in the acute treatment of major depressive disorder.

Khan A, Bose A, Alexopoulos GS, Gommoll C, Li D, Gandhi C.

Clin Drug Investig. 2007;27(7):481-92.

PMID:
17563128

Supplemental Content

Support Center